1. Home
  2. MSW vs VNRX Comparison

MSW vs VNRX Comparison

Compare MSW & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MSW
  • VNRX
  • Stock Information
  • Founded
  • MSW 2012
  • VNRX N/A
  • Country
  • MSW Hong Kong
  • VNRX United States
  • Employees
  • MSW N/A
  • VNRX N/A
  • Industry
  • MSW
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • MSW
  • VNRX Health Care
  • Exchange
  • MSW NYSE
  • VNRX Nasdaq
  • Market Cap
  • MSW N/A
  • VNRX 58.6M
  • IPO Year
  • MSW 2024
  • VNRX N/A
  • Fundamental
  • Price
  • MSW $3.59
  • VNRX $0.57
  • Analyst Decision
  • MSW
  • VNRX Strong Buy
  • Analyst Count
  • MSW 0
  • VNRX 4
  • Target Price
  • MSW N/A
  • VNRX $4.17
  • AVG Volume (30 Days)
  • MSW 64.5K
  • VNRX 119.1K
  • Earning Date
  • MSW 05-25-2025
  • VNRX 03-31-2025
  • Dividend Yield
  • MSW N/A
  • VNRX N/A
  • EPS Growth
  • MSW 18.78
  • VNRX N/A
  • EPS
  • MSW 0.20
  • VNRX N/A
  • Revenue
  • MSW $31,769,612.00
  • VNRX $1,285,827.00
  • Revenue This Year
  • MSW N/A
  • VNRX $71,446.31
  • Revenue Next Year
  • MSW N/A
  • VNRX N/A
  • P/E Ratio
  • MSW $17.66
  • VNRX N/A
  • Revenue Growth
  • MSW 30.91
  • VNRX 97.50
  • 52 Week Low
  • MSW $2.12
  • VNRX $0.43
  • 52 Week High
  • MSW $10.58
  • VNRX $1.02
  • Technical
  • Relative Strength Index (RSI)
  • MSW N/A
  • VNRX 50.47
  • Support Level
  • MSW N/A
  • VNRX $0.51
  • Resistance Level
  • MSW N/A
  • VNRX $0.57
  • Average True Range (ATR)
  • MSW 0.00
  • VNRX 0.04
  • MACD
  • MSW 0.00
  • VNRX 0.00
  • Stochastic Oscillator
  • MSW 0.00
  • VNRX 60.00

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: